Trial Profile
A study to compare the clinical usefulness of "routine" versus "rescue" therapeutic drug monitoring (TDM) interventions in chronic myeloid leukaemia (CML) patients: a multicentre parallel group open-label randomised clinical trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Feb 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms I-COME
- 31 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 27 Aug 2009 New trial record